Wellnex Launches Medical Cannabis Brand

Launch of Wellness Life & Appointment of Industry Expert to
Lead Joint Venture

Wellnex Life Limited (ASX: WNX) is pleased to announce the launch of Wellness Life, a
new medicinal cannabis brand will officially launch on 1 July 2024.
To further strengthen this exciting venture and ensure the launch receives the support
and focus, Wellnex Life and OneLife Botanicals is pleased to advise the appointment of
Dr Sylvia Victor. Dr Sylvia Victor, an esteemed industry expert, will oversee all activities
with the joint venture using her extensive experience in healthcare and alternative
medicines to drive the success of the new Wellness Life brand.
Product Launch and Distribution

Under the Wellness Life brand, Wellnex Life will launch a full range of medicinal
cannabis products. These products, designed with insights from best-selling market
trends, will be made available through the extensive Chemist Warehouse network in
Australia. Additionally, we plan to distribute these products to other pharmaceutical
customers, broadening our market reach.

We are also pleased to announce that InstantConsult, a leading telehealth provider
associated with Chemist Warehouse, will be able to prescribe Wellness Life
products.

Medicinal Cannabis Market Overview

The Special Access Scheme Category B (SAS-B) allows medical practitioners to
prescribe medicinal cannabis products to patients not included in the Australian
Register of Therapeutic Goods.

The medicinal cannabis market in Australia is projected to reach USD 356.70 million
in 2024, with a compound annual growth rate (CAGR) of 4.58% from 2024 to 2029,
potentially reaching USD 446.30 million by 2029 (Source: Statista)

Full ASX Announcement – WNX_Wellnex_Launches_Medicinal_Cannabis_Brand_Wellness_Life.pdf (yourir.info)